# InSilicoTrials Technologies S.r.l.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/insilicotrials-technologies-s-r-l

- Industry: Software
- Headquarters: Milan, Italy
- Website: www.insilicotrials.com
- Total disclosed funding: $3.5M
- Latest round: Series A (Jul 27, 2020)
- Investors on record: 3

## About

Founded in 2016 and based in Milan, Italy, InSilicoTrials Technologies S.r.l. operates as a provider of a web-based platform that enables healthcare companies and researchers to have an easy-to-use tool to view and analyze the modeling and simulation results.Based in Italy, InSilicoTrials Technologies S.r.l. offers a platform for modeling and simulation to support healthcare research and development. In December 2025, InSilicoTrials Technologies S.r.l. received USD 30 million in grant funding from new investor Advanced Research Projects Agency for Health. InSilicoTrials provides a cloud-based in-silico drug development platform offering computational models, AI-driven simulations, and virtual patient technologies to predict drug safety and efficacy across the R&D lifecycle. The company will use the funding to develop next-generation virtual heart models for cardiac safety prediction, leveraging its cloud-based platform and cardiotoxicity expertise as part of the CARDIOVERSE initiative.

## Funding rounds

- Series A, Jul 27, 2020, $3.5M — United Ventures, Pi Campus
- Seed, Mar 19, 2019 — StartUp Health

## Investors

- StartUp Health (https://capitalatlas.ai/funds/startup-health) — Seed
- United Ventures (https://capitalatlas.ai/funds/united-ventures) — Series A
- Pi Campus (https://capitalatlas.ai/funds/pi-campus) — Series A